55 results on '"McFadden, Eugene"'
Search Results
2. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review
3. Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI
4. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis
5. Independence of clinical events committees: A consensus statement from clinical research organizations
6. Periprocedural Myocardial Injury: Pathophysiology, Prognosis, and Prevention
7. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
8. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention
9. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document
10. Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document
11. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina
12. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials
13. Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice)
14. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)
15. Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
16. 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial)
17. Chronic myocardial infarction detection and characterization during coronary artery calcium scoring acquisitions
18. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
19. Reply: Periprocedural PCI Myocardial Biomarker Elevation and Mortality
20. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: Insights from a systematic overview of randomized trials in light of the drug-eluting stent era
21. Noninvasive Assessment of Coronary Plaque Burden Using Multislice Computed Tomography
22. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents
23. “Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions
24. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
25. Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris
26. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
27. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure
28. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction
29. No change in endothelial-dependent vasomotion late after coronary irradiation
30. effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients
31. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study
32. CORE LABORATORY ASSESSMENT OF NON-FATAL Q-WAVE MYOCARDIAL INFARCTION IN THE GLOBAL LEADERS TRIAL: METHODS AND FINDINGS
33. Reply: Following Renal Outcomes With Staging in Percutaneous Coronary Intervention Trials
34. IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS
35. Endovascular treatment for dissection of the descending aorta
36. Usefulness of Multislice Computed Tomographic Coronary Angiography to Assess In-Stent Restenosis
37. Immediate and One-Year Outcome of Percutaneous Intervention of Saphenous Vein Graft Disease With Paclitaxel-Eluting Stents
38. Comparison of Short- (One Month) and Long- (Twelve Months) Term Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents in 293 Consecutive Patients With Diabetes Mellitus (from the RESEARCH and T-SEARCH Registries)
39. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance
40. Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusions
41. TCT-13 Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents
42. Standard versus user-interactive assessment of significant coronary stenoses with multislice computed tomography coronary angiography
43. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians
44. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings
45. Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings
46. Everolimus-eluting versus paclitaxel-eluting stents – Authors' reply
47. Ostial left main coronary stenosis in a frequent flyer
48. 1022-80 Safety and feasibility of paclitaxel-eluting stents in the treatment of ST-elevation acute myocardial infarction
49. 862-4 Comparative incidence of angiographically proven early stent thrombosis in unselected sirolimus- and paclitaxel-eluting stent populations
50. 1024-54 Low repeat revascularization rates following drug-eluting stent implantation in de novo bifurcation lesions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.